Policy Perspective
COGR Testimony at NIH Hearings on March-in Rights
NIH has denied the request from Essential Inventions, Inc. to exercise march-in rights under The Bayh-Dole Act in connection with the pricing of Norvir, marketed by Abbott Laboratories for the treatment of patients with HIV/AIDS. The decision and related materials are available online.
Miscellaenous
The revised Information Quality Bulletin for Peer Review, issued by the Office of Information and Regulatory Affairs (OIRA) within the Office of Management and Budget (OMB), provides updated and detailed guidance to federal agencies regarding the peer review of influential scientific information disseminated to the public. Unlike the prior guidelines, which merely encouraged peer review, this Bull
COGR Meeting Report - February 2011
The COGR Meeting Report from February 2011 provides a detailed overview of the key issues and developments affecting research universities in the areas of costing policies, contracts and intellectual property, and research compliance and administration. The report emphasizes significant audit activities led by the Federal Office of Inspectors General, especially in regards to administrative and cl
